Open access · CC-BY
via OpenAlex
GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin
Jing Ouyang, Stéphane Isnard, John Lin, Brandon Fombuena, Xiaorong Peng, Yaokai Chen, Jean‐Pierre Routy
Frontiers in Endocrinology · 2020 · ▲ 38 citations
Abstract
Weight gain and obesity are global health concerns contributing to morbidity with increased risks of cardiovascular disease, diabetes, liver steatohepatitis and cancer. Pharmacological therapies or bariatric surgery are often required for those who fail to adhere to diet and lifestyle modifications. Metformin, a widely used antidiabetic agent, seems to have a health benefit beyond its anti-hyperglycemic properties, with few side effects. Emerging evidence shows weight loss to be associated with metformin in both diabetic and non-diabetic individuals. Recently, the growth differentiation factor 15 (GDF-15), a member of the transforming growth factor beta superfamily, has been identified as a key mediator of metformin-induced weight loss. Metformin increases the secretion of GDF-15, which binds exclusively to glial cell-derived neurotrophic factor family receptor alpha-like (GFRAL). This gut-brain cytokine works as a prominent player in reducing food intake and body weight in health and disease, like anorexia nervosa and cancer. Herein, we critically review advances in the understanding of the weight-reducing effects of metformin via the GDF-15 pathway.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fendo.2020.581839
- Canonical
- link ↗
- Fetched
- 2026-08-24 MST
Cite this
APA
Ouyang, J., Isnard, S., Lin, J., Fombuena, B., Peng, X., Chen, Y., & Routy, J. (2020). GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin. <em>Frontiers in Endocrinology</em>. https://doi.org/10.3389/fendo.2020.581839
Vancouver
Ouyang J, Isnard S, Lin J, Fombuena B, Peng X, Chen Y, et al. GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin. Frontiers in Endocrinology. 2020. doi:10.3389/fendo.2020.581839.
BibTeX
@article{jing2020GDFasa,
title = {GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin},
author = {Jing Ouyang and Stéphane Isnard and John Lin and Brandon Fombuena and Xiaorong Peng and Yaokai Chen and Jean‐Pierre Routy},
journal = {Frontiers in Endocrinology},
year = {2020},
doi = {10.3389/fendo.2020.581839},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Annals of Periodontology 1998
Citation only
Osteoporosis: A Possible Modifying Factor in Oral Bone Loss
Nutrients 2022
Open access · CC-BY
Intermittent Fasting: Potential Bridge of Obesity and Diabetes to Health?
Medicinski Glasnik 2025
Open access · CC-BY
Knowledge and practice of intermittent fasting: a cross-sectional study among university students in the United Arab Emirates
Obesity Research 2005
Open access · OA
Evidence in Female Rhesus Monkeys (Macaca mulatta) that Nighttime Caloric Intake is not Associated with Weight Gain
Journal of the American Society of Nephrology 2006
Citation only
Obesity, Arterial Stiffness, and Cardiovascular Risk
Journal of Education Health and Sport 2025
Open access · CC-BY